GlassScriptPhysician profile
Scott N Pinchot
NPI 1598713158
$1,797.38
in general payments reported to CMS, 2019-2025
28 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $18.13 · 2021: $72.48 · 2022: $46.50 · 2023: $372 · 2024: $468 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $492.99 | 2019-2022 | |
| Ethicon US, LLC | $183.60 | 2023 | Echelon Flex, Echelon Circular |
| Medtronic, INC. | $102.80 | 2023-2024 | Interstim |
| Creo Medical INC. | $100.00 | 2024 | Speedboat Ultraslim (Sb1l) |
| Boston Scientific Corporation | $95.71 | 2024 | Rezum Generator |
| Kerecis Limited | $95.61 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $80.41 | 2024-2025 | Stravix Pl, Oasis |
| Takeda Pharmaceuticals U.S.A., INC. | $77.19 | 2022-2024 | Gattex |
| Becton, Dickinson and Company | $66.20 | 2019-2025 | Bard Urinary Drainage Bag, Magic3 Intermittent Catheter |
| Olympus America INC. | $57.02 | 2019-2023 | Itind System, Soltive |
| Merck Sharp & Dohme LLC | $54.24 | 2019-2025 | Keytruda, Lynparza |
| Csl Behring | $46.84 | 2023 | Kcentra |
| Vertex Pharmaceuticals Incorporated | $35.56 | 2025 | |
| Electromed, INC. | $33.43 | 2019 | |
| Trevena, INC. | $30.46 | 2024 | Olinvyk |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $29.89 | 2024 | Artegraft Vascular Graft |
| Tei Biosciences INC | $27.52 | 2019 | |
| Sumitomo Pharma America, INC. | $25.89 | 2025 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $23.64 | 2019 | |
| Thd America, INC. | $20.34 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.13 | 2020 | |
| Conmed Corporation | $15.86 | 2024 | Airseal |
| Antares Pharma, INC. | $15.76 | 2025 | Xyosted |
| Bard Peripheral Vascular, INC. | $14.56 | 2025 | Venovo |
| Procept Biorobotics Corporation | $14.14 | 2021 | |
| Teleflex LLC | $13.61 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $13.56 | 2021 | |
| Abbott Laboratories | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Pinchot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.